Log In
BCIQ
Print this Print this
 

Cysview, Hexvix, hexaminolevulinate

  Manage Alerts
Collapse Summary General Information
Company Photocure ASA
DescriptionAminolevulinic acid (ALA) derivative photosensitizer
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose papillary bladder cancer
Regulatory Designation U.S. - Priority Review (Diagnose papillary bladder cancer)
PartnerIpsen Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$8.8M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/17/2011

Undisclosed

$8.8M

Undisclosed

Get a free BioCentury trial today